• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑郁症患者血小板L-色氨酸转运缺陷的证据。

Evidence for a defective platelet L-tryptophan transport in depressed patients.

作者信息

Gronier B, Azorin J M, Dassa D, Jeanningros R

机构信息

Unité de Psychiatrie Biologique, C.N.R.S., Faculté de Médecine, Marseille, France.

出版信息

Int Clin Psychopharmacol. 1993 Summer;8(2):87-93. doi: 10.1097/00004850-199300820-00002.

DOI:10.1097/00004850-199300820-00002
PMID:8345162
Abstract

The kinetic characteristics of platelet L-tryptophan uptake were investigated in 23 untreated depressed patients and 18 healthy volunteers. A significant increase of 50% in the apparent Michaelis constant (Km) was observed in depressed patients compared with controls, without significant change in the maximal velocity (Vmax). After 1 month of successful antidepressant treatment the mean Km value decreased significantly and reached the control value. This result raises the possibility that the decrease in platelet tryptophan uptake affinity is a state-dependent marker for depression. It is likely that the transport alteration results in a decrease in platelet tryptophan accumulation. The effect of this peripheral membrane defect on brain serotonin function is discussed.

摘要

对23名未经治疗的抑郁症患者和18名健康志愿者的血小板L-色氨酸摄取动力学特征进行了研究。与对照组相比,抑郁症患者的表观米氏常数(Km)显著增加了50%,而最大速度(Vmax)没有显著变化。经过1个月成功的抗抑郁治疗后,平均Km值显著下降并达到对照组水平。这一结果增加了血小板色氨酸摄取亲和力降低是抑郁症状态依赖性标志物的可能性。转运改变很可能导致血小板色氨酸积累减少。本文讨论了这种外周膜缺陷对脑血清素功能的影响。

相似文献

1
Evidence for a defective platelet L-tryptophan transport in depressed patients.抑郁症患者血小板L-色氨酸转运缺陷的证据。
Int Clin Psychopharmacol. 1993 Summer;8(2):87-93. doi: 10.1097/00004850-199300820-00002.
2
Platelet serotonin and plasma tryptophan in depressed patients: effect of drug treatment and clinical outcome.抑郁症患者的血小板5-羟色胺和血浆色氨酸:药物治疗效果及临床转归
Neuropsychopharmacology. 1994 May;10(3):207-14. doi: 10.1038/npp.1994.23.
3
Red blood cell L-tryptophan uptake in depression. II. Effect of an antidepressant treatment.
Psychiatry Res. 1997 Feb 7;66(2-3):87-96. doi: 10.1016/s0165-1781(96)02885-5.
4
[Changes in the kinetics of erythrocyte membrane transport of tryptophan in depression].[抑郁症患者色氨酸红细胞膜转运动力学的变化]
Encephale. 1989 Mar-Apr;15(2):251-4.
5
Red blood cell L-tryptophan uptake in depression: kinetic analysis in untreated depressed patients and healthy volunteers.抑郁症患者红细胞对L-色氨酸的摄取:未治疗的抑郁症患者与健康志愿者的动力学分析
Psychiatry Res. 1996 Jul 31;63(2-3):151-9. doi: 10.1016/0165-1781(96)02805-3.
6
Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment.重度抑郁症中的血小板血清素能指标:5-HT2A受体上调,抗抑郁治疗未改变此情况。
Psychiatry Res. 1997 Feb 7;66(2-3):73-85. doi: 10.1016/s0165-1781(96)03046-6.
7
Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitors.与未接受过5-羟色胺摄取抑制剂治疗的抑郁症患者血小板结合的[3H]-丙咪嗪的最大结合量降低。
Psychopharmacology (Berl). 1986;89(4):456-61. doi: 10.1007/BF02412121.
8
Does platelet serotonin receptor supersensitivity accompany endogenous depression?
Biol Psychiatry. 1989 Feb 15;25(4):375-81. doi: 10.1016/0006-3223(89)90190-x.
9
Increased serotonin platelet uptake after tianeptine administration in depressed patients.
Biol Psychiatry. 1991 Sep 15;30(6):609-17. doi: 10.1016/0006-3223(91)90030-p.
10
Lack of association between platelet tritiated imipramine binding and clinical status of depressed patients on chronic antidepressant treatment.慢性抗抑郁治疗的抑郁症患者血小板中氚标记丙咪嗪结合与临床状态之间缺乏相关性。
Eur Neuropsychopharmacol. 1994 Mar;4(1):7-14. doi: 10.1016/0924-977x(94)90309-3.

引用本文的文献

1
"Add-On"-therapy with an individualized preparation consisting of free amino acids for patients with a major depression.针对重度抑郁症患者,采用由游离氨基酸组成的个体化制剂进行“附加”治疗。
Eur Arch Psychiatry Clin Neurosci. 2007 Jun;257(4):222-9. doi: 10.1007/s00406-007-0711-9.